As NR4A3 methylation associated with GC patient shorter survival, we performed immunohistochemistry (IHC) to investigate NR4A3 expression in tissue microarrays of another independent cohort containing 128 GC tumor samples (Supplementary Table S1). This evidence concerns the gene NR4A3 and neoplasm.